A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design.

[1]  T. Smith,et al.  Attributable fraction estimates and case definitions for malaria in endemic areas. , 1994, Statistics in medicine.

[2]  J. Kihonda,et al.  Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. , 1993, Acta tropica.

[3]  P. Alonso,et al.  Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia , 1993, The Lancet.

[4]  J. Beier,et al.  Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A , 1992, Infection and immunity.

[5]  M. Patarroyo,et al.  Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria , 1991, Clinical and experimental immunology.

[6]  M. Tanner,et al.  In vitro resistance patterns of Plasmodium falciparum to chloroquine--a reflection of strain-specific immunity? , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  Pedro Romero,et al.  A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria , 1988, Nature.

[8]  P. Romero,et al.  Induction of protective immunity against experimental infection with malaria using synthetic peptides , 1987, Nature.

[9]  Myron M. Levine,et al.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites , 1987, Nature.

[10]  S. Hoffman,et al.  SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE , 1987, The Lancet.

[11]  B. Betschart,et al.  Quantitative determination of chloroquine and desethylchloroquine in biological fluids by high performance thin layer chromatography. , 1986, Acta tropica.

[12]  D. Clyde,et al.  Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. , 1975, The American journal of tropical medicine and hygiene.

[13]  R. Miller,et al.  Specificity of protection of man immunized against sporozoite‐induced falciparum malaria , 1973, The American journal of the medical sciences.

[14]  J. Vanderberg,et al.  Immunization of man against sporozite-induced falciparum malaria , 1973, The American journal of the medical sciences.

[15]  T. Freyvogel,et al.  Report on a limited anopheline survey at Ifakara, South-Eastern Tanzania. , 1968, Acta tropica.

[16]  S. Kitchen,et al.  Is the Acquired Homologous Immunity to P. Vivax Equally Effective against Sporozoites and Trophozoites?1 , 1936 .

[17]  M. Patarroyo,et al.  Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years. , 1992, Vaccine.

[18]  K. Mendis,et al.  Malaria vaccine research - a game of chess. , 1991 .

[19]  R. Hayes,et al.  Design and conduct of field trials of malaria vaccines. , 1991 .

[20]  M. Tanner,et al.  Malaria transmission and develoment of anti-sporozoite antibodies in a rural african community , 1986 .